| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |